Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C

ClinicalTrials.gov ID: NCT02621892

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02621892. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 12:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase 3, 12-week, randomized, double-blind, placebo-controlled, multi-center study will evaluate the safety and efficacy of tenapanor in subjects with constipation-predominant irritable bowel syndrome (IBS-C) as defined by the ROME III criteria and who have active disease as determined after a two-week screening period. Subjects who qualify and are randomized into the study will either receive 50mg BID of tenapanor or placebo BID for 12 week treatment period and then undergo a 4 week placebo controlled randomized withdrawal.

Study identification

NCT ID
NCT02621892
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Ardelyx
Industry
Enrollment
606 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2015 (Type not available)
Primary completion
Mar 2017 (Actual)
Completion
Apr 2017 (Actual)
Last update posted
Apr 21, 2020

2015 – 2017

United States locations

U.S. sites
111
U.S. states
29
U.S. cities
95
Facility City State ZIP Site status
Ardelyx Investigative Site 149 Birmingham Alabama 35216 —
Ardelyx Investigative Site 114 Birmingham Alabama 35242 —
Ardelyx Investigative Site 103 Huntsville Alabama 35801 —
Ardelyx Investigative Site 100 Huntsville Alabama 35802 —
Ardelyx Investigative Site 145 Chandler Arizona 85224 —
Ardelyx Investigative Site 210 Phoenix Arizona 85018 —
Ardelyx Investigative Site 296 Phoenix Arizona 85018 —
Ardelyx Investigative Site 277 Tempe Arizona 85283 —
Ardelyx Investigative Site 269 Tucson Arizona 85704 —
Ardelyx Investigative Site 187 Tucson Arizona 85712 —
Ardelyx Investigative Site 199 Tucson Arizona 85741 —
Ardelyx Investigative Site 140 Harrisburg Arkansas 72432 —
Ardelyx Investigative Site 274 Little Rock Arkansas 72209 —
Ardelyx Investigative Site 161 Little Rock Arkansas 72211 —
Ardelyx Investigative Site 122 Little Rock Arkansas 72212 —
Ardelyx Investigative Site 129 North Little Rock Arkansas 72117 —
Ardelyx Investigative Site 105 Canoga Park California 91303 —
Ardelyx Investigative Site 143 Chula Vista California 91910 —
Ardelyx Investigative Site 146 Encino California 91436 —
Ardelyx Investigative Site 147 Encino California 91436 —
Ardelyx Investigative Site 107 Lomita California 90717 —
Ardelyx Investigative Site 112 North Hollywood California 91606 —
Ardelyx Investigative Site 110 Northridge California 91325 —
Ardelyx Investigative Site 294 San Diego California 92123 —
Ardelyx Investigative Site 108 Thousand Oaks California 91360 —
Ardelyx Investigative Site 178 Cutler Bay Florida 33157 —
Ardelyx Investigative Site 131 Fort Lauderdale Florida 33308 —
Ardelyx Investigative Site 136 Hialeah Florida 33012 —
Ardelyx Investigative Site 130 Hialeah Florida 33016 —
Ardelyx Investigative Site 287 Homestead Florida 33030 —
Ardelyx Investigative Site 106 Miami Florida 33186 —
Ardelyx Investigative Site 127 Miami Lakes Florida 33014 —
Ardelyx Investigative Site 123 Miami Springs Florida 33166 —
Ardelyx Investigative Site 126 Pompano Beach Florida 33060 —
Ardelyx Investigative Site 132 Port Orange Florida 32129 —
Ardelyx Investigative Site 150 St. Petersburg Florida 33709 —
Ardelyx Investigative Site 254 West Palm Beach Florida 33409 —
Ardelyx Investigative Site 234 Athens Georgia 30607 —
Ardelyx Investigative Site 138 Atlanta Georgia 30312 —
Ardelyx Investigative Site 148 Atlanta Georgia 30342 —
Ardelyx Investigative Site 137 Norcross Georgia 30071 —
Ardelyx Investigative Site 213 Savannah Georgia 31406 —
Ardelyx Investigative Site 124 Snellville Georgia 30078 —
Ardelyx Investigative Site 157 Boise Idaho 83642 —
Ardelyx Investigative Site 102 Blue Island Illinois 60406 —
Ardelyx Investigative Site 162 Evanston Illinois 60201 —
Ardelyx Investigative Site 202 Oak Lawn Illinois 60453 —
Ardelyx Investigative Site 259 Topeka Kansas 66606 —
Ardelyx Investigative Site 192 Crowley Louisiana 70526 —
Ardelyx Investigative Site 188 Metairie Louisiana 70006 —
Ardelyx Investigative Site 177 Monroe Louisiana 71201 —
Ardelyx Investigative Site 198 Zachary Louisiana 70791 —
Ardelyx Investigative Site 278 Hagerstown Maryland 21742 —
Ardelyx Investigative Site 255 Towson Maryland 21204 —
Ardelyx Investigative Site 135 Boston Massachusetts 02131 —
Ardelyx Investigative Site 267 Brockton Massachusetts 02302 —
Ardelyx Investigative Site 119 Caro Michigan 48723 —
Ardelyx Investigative Site 128 Chesterfield Michigan 48047 —
Ardelyx Investigative Site 224 Saginaw Michigan 48604 —
Ardelyx Investigative Site 125 Belton Missouri 64012 —
Ardelyx Investigative Site 156 Billings Montana 59102 —
Ardelyx Investigative Site 142 Omaha Nebraska 68114 —
Ardelyx Investigative Site 275 Las Vegas Nevada 89103 —
Ardelyx Investigative Site 276 Las Vegas Nevada 89119 —
Ardelyx Investigative Site 182 Las Vegas Nevada 89128 —
Ardelyx Investigative Site 175 Vineland New Jersey 08360 —
Ardelyx Investigative Site 293 Albuquerque New Mexico 87108 —
Ardelyx Investigative Site 151 Brooklyn New York 11215 —
Ardelyx Investigative Site 170 Great Neck New York 11023 —
Ardelyx Investigative Site 225 Hartsdale New York 10530 —
Ardelyx Investigative Site 206 New Windsor New York 12553 —
Ardelyx Investigative Site 183 New York New York 10036 —
Ardelyx Investigative Site 226 Asheville North Carolina 28801 —
Ardelyx Investigative Site 166 Charlotte North Carolina 28210 —
Ardelyx Investigative Site 205 Fayetteville North Carolina 28304 —
Ardelyx Investigative Site 104 Greensboro North Carolina 27403 —
Ardelyx Investigative Site 174 Kinston North Carolina 28501 —
Ardelyx Investigative Site 280 Winston-Salem North Carolina 27103 —
Ardelyx Investigative Site 172 Beavercreek Ohio 45432 —
Ardelyx Investigative Site 223 Cincinnati Ohio 45219 —
Ardelyx Investigative Site 201 Cincinnati Ohio 45234 —
Ardelyx Investigative Site 139 Columbus Ohio 43214 —
Ardelyx Investigative Site 173 Dayton Ohio 45429 —
Ardelyx Investigative Site 171 Huber Heights Ohio 45424 —
Ardelyx Investigative Site 117 Mentor Ohio 44060 —
Ardelyx Investigative Site 247 Springfield Ohio 45504 —
Ardelyx Investigative Site 144 Jenkintown Pennsylvania 19046 —
Ardelyx Investigative Site 289 Mt. Pleasant South Carolina 29464 —
Ardelyx Investigative Site 184 Myrtle Beach South Carolina 29588 —
Ardelyx Investigative Site 281 North Charleston South Carolina 29406 —
Ardelyx Investigative Site 261 Sioux Falls South Dakota 57108 —
Ardelyx Investigative Site 134 Chattanooga Tennessee 37421 —
Ardelyx Investigative Site 121 Franklin Tennessee 37064 —
Ardelyx Investigative Site 189 Hermitage Tennessee 37076 —
Ardelyx Investigative Site 133 Jackson Tennessee 38305 —
Ardelyx Investigative Site 109 Knoxville Tennessee 37909 —
Ardelyx Investigative Site 235 Nashville Tennessee 37211 —
Ardelyx Investigative Site 164 Corpus Christi Texas 78413 —
Ardelyx Investigative Site 197 Corsicana Texas 75110 —
Ardelyx Investigative Site 185 Houston Texas 77079 —
Ardelyx Investigative Site 120 Houston Texas 77090 —
Ardelyx Investigative Site 113 McKinney Texas 75071 —
Ardelyx Investigative Site 111 Plano Texas 75093 —
Ardelyx Investigative Site 118 Plano Texas 75093 —
Ardelyx Investigative Site 101 San Antonio Texas 78215 —
Ardelyx Investigative Site 240 San Antonio Texas 78229 —
Ardelyx Investigative Site 159 Orem Utah 84058 —
Ardelyx Investigative Site 207 Sandy City Utah 84094 —
Ardelyx Investigative Site 155 South Ogden Utah 84405 —
Ardelyx Investigative Site 231 Norfolk Virginia 23507 —
Ardelyx Investigative Site 141 Richmond Virginia 23294 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02621892, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2020 · Synced Nov 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.